Literature DB >> 22496237

CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.

Douglas S Kwon1, Mathieu Angin, Tomoyuki Hongo, Kenneth M Law, Jessica Johnson, Filippos Porichis, Meghan G Hart, David F Pavlik, Daniel P Tighe, Daniel G Kavanagh, Hendrik Streeck, Marylyn M Addo, Daniel E Kaufmann.   

Abstract

T cell dysfunction in the presence of ongoing antigen exposure is a cardinal feature of chronic viral infections with persistent high viremia, including HIV-1. Although interleukin-10 (IL-10) has been implicated as an important mediator of this T cell dysfunction, the regulation of IL-10 production in chronic HIV-1 infection remains poorly understood. We demonstrated that IL-10 is elevated in the plasma of individuals with chronic HIV-1 infection and that blockade of IL-10 signaling results in a restoration of HIV-1-specific CD4 T cell proliferation, gamma interferon (IFN-γ) secretion, and, to a lesser extent, IL-2 production. Whereas IL-10 blockade leads to restoration of IFN-γ secretion by HIV-1-specific CD4 T cells in all categories of subjects investigated, significant enhancement of IL-2 production and improved proliferation of CD4 T helper cells are restricted to viremic individuals. In peripheral blood mononuclear cells (PBMCs), this IL-10 is produced primarily by CD14(+) monocytes, but its production is tightly controlled by regulatory T cells (Tregs), which produce little IL-10 directly. When Tregs are depleted from PBMCs of viremic individuals, the effect of the IL-10 signaling blockade is abolished and IL-10 production by monocytes decreases, while the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), increases. The regulation of IL-10 by Tregs appears to be mediated primarily by contact or paracrine-dependent mechanisms which involve IL-27. This work describes a novel mechanism by which regulatory T cells control IL-10 production and contribute to dysfunctional HIV-1-specific CD4 T cell help in chronic HIV-1 infection and provides a unique mechanistic insight into the role of regulatory T cells in immune exhaustion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496237      PMCID: PMC3393541          DOI: 10.1128/JVI.06251-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.

Authors:  H D Shin; C Winkler; J C Stephens; J Bream; H Young; J J Goedert; T R O'Brien; D Vlahov; S Buchbinder; J Giorgi; C Rinaldo; S Donfield; A Willoughby; S J O'Brien; M W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.

Authors:  Daria Trabattoni; Marina Saresella; Mara Biasin; Adriano Boasso; Luca Piacentini; Pasquale Ferrante; Haidong Dong; Renato Maserati; Gene M Shearer; Lieping Chen; Mario Clerici
Journal:  Blood       Date:  2002-12-05       Impact factor: 22.113

3.  Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains.

Authors:  P Ancuta; Y Bakri; N Chomont; H Hocini; D Gabuzda; N Haeffner-Cavaillon
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

4.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

6.  IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections.

Authors:  M Denis; E Ghadirian
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

7.  Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.

Authors:  Susanne Knapp; Branwen J W Hennig; Angela J Frodsham; Lyna Zhang; Simon Hellier; Mark Wright; Rob Goldin; Adrian V S Hill; Howard C Thomas; Mark R Thursz
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

8.  Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals.

Authors:  C Graziosi; G Pantaleo; K R Gantt; J P Fortin; J F Demarest; O J Cohen; R P Sékaly; A S Fauci
Journal:  Science       Date:  1994-07-08       Impact factor: 47.728

9.  Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus.

Authors:  Seiji Miyazoe; Keisuke Hamasaki; Keisuke Nakata; Yuji Kajiya; Kayo Kitajima; Kazuhiko Nakao; Manabu Daikoku; Hiroshi Yatsuhashi; Michiaki Koga; Michitami Yano; Katsumi Eguchi
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  23 in total

1.  HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.

Authors:  Ankita Garg; Stephen A Spector
Journal:  J Infect Dis       Date:  2013-09-01       Impact factor: 5.226

Review 2.  Animal models for viral infection and cell exhaustion.

Authors:  Colleen S McGary; Guido Silvestri; Mirko Paiardini
Journal:  Curr Opin HIV AIDS       Date:  2014-09       Impact factor: 4.283

Review 3.  Understanding HIV latency: the road to an HIV cure.

Authors:  Matthew S Dahabieh; Emilie Battivelli; Eric Verdin
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

4.  Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.

Authors:  Filippos Porichis; Meghan G Hart; Jennifer Zupkosky; Lucie Barblu; Douglas S Kwon; Ashley McMullen; Thomas Brennan; Rafi Ahmed; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Understanding the mechanism of action of cytomegalovirus-induced regulatory T cells.

Authors:  Adriana Tovar-Salazar; Adriana Weinberg
Journal:  Virology       Date:  2020-05-10       Impact factor: 3.616

Review 6.  Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Authors:  Morgan A Reuter; Carolina Pombo; Michael R Betts
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

7.  In vitro assay to evaluate the impact of immunoregulatory pathways on HIV-specific CD4 T cell effector function.

Authors:  Filippos Porichis; Meghan G Hart; Jennifer Zupkosky; Lucie Barblu; Daniel E Kaufmann
Journal:  J Vis Exp       Date:  2013-10-15       Impact factor: 1.355

Review 8.  Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection.

Authors:  Sanjay Swaminathan; Lue Dai; H Clifford Lane; Tomozumi Imamichi
Journal:  Cytokine Growth Factor Rev       Date:  2013-08-17       Impact factor: 7.638

9.  Tuberculosis distorts the inhibitory impact of interleukin-10 in HIV infection.

Authors:  Shivan Chetty; Filippos Porichis; Pamla Govender; Jennifer Zupkosky; Musie Ghebremichael; Mona Pillay; Bruce D Walker; Thumbi Ndung'u; Daniel E Kaufmann; Victoria O Kasprowicz
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

10.  Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.

Authors:  Filippos Porichis; Meghan G Hart; Alexandra Massa; Holly L Everett; Antigoni Morou; Jonathan Richard; Nathalie Brassard; Maxime Veillette; Muska Hassan; Ngoc Le Ly; Jean-Pierre Routy; Gordon J Freeman; Mathieu Dubé; Andrés Finzi; Daniel E Kaufmann
Journal:  J Immunol       Date:  2018-06-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.